Last reviewed · How we verify
Balanced salt solution — Competitive Intelligence Brief
marketed
Ophthalmic irrigating solution
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Balanced salt solution (Balanced salt solution) — Corewell Health East. Balanced salt solution provides electrolyte and osmotic support to maintain corneal hydration and clarity during ophthalmic surgery.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Balanced salt solution TARGET | Balanced salt solution | Corewell Health East | marketed | Ophthalmic irrigating solution | ||
| BSS Plus | BSS Plus | Adam Fedyk, MD, FACS | marketed | Ophthalmic irrigating solution |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Ophthalmic irrigating solution class)
- Adam Fedyk, MD, FACS · 1 drug in this class
- Corewell Health East · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Balanced salt solution CI watch — RSS
- Balanced salt solution CI watch — Atom
- Balanced salt solution CI watch — JSON
- Balanced salt solution alone — RSS
- Whole Ophthalmic irrigating solution class — RSS
Cite this brief
Drug Landscape (2026). Balanced salt solution — Competitive Intelligence Brief. https://druglandscape.com/ci/balanced-salt-solution. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab